parsons supports u.s. indo-pacific defense with $68.5 million u.s. army infrastructure contract
CHANTILLY, Va., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was awarded a...
CHANTILLY, Va., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was awarded a...
TORONTO, Sept. 9, 2024 /PRNewswire/ - New Gold Inc. ("New Gold" or the "Company") (TSX: NGD) (NYSE American: NGD) is...
Vancouver, British Columbia--(Newsfile Corp. - September 9, 2024) - Dryden Gold Corp. (TSXV: DRY) (OTCQB: DRYGF) ("Dryden Gold" or the...
- Provides Update on Engagement with Riot -- Special Meeting to be Held In-Person - This news release constitutes a...
WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio...
MAHWAH, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a global leader in application security and delivery solutions...
HOUSTON, Sept. 9, 2024 /PRNewswire/ -- KBR (NYSE: KBR) announced today that it has been awarded a contract for its...
Tel-Aviv, Israel, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a...
High dose batoclimab achieved 76% response rate in patients uncontrolled on antithyroid drugs (ATDs) at week 12High dose batoclimab achieved...
Vancouver, British Columbia--(Newsfile Corp. - September 9, 2024) - First Hydrogen Corp. (TSXV: FHYD) (OTC Pink: FHYDF) (FSE: FIT) ("FIRST...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that Saint-Denis Hospital Center is adopting the use of the Masimo SafetyNet® cloud-based...
DALLAS--(BUSINESS WIRE)--Kosmos Energy Ltd. (the "Offeror", “Kosmos”, or the “Company”) (NYSE/LSE:KOS) announces the launch of its offers to purchase for...
DALLAS--(BUSINESS WIRE)--Kosmos Energy Ltd. (“Kosmos” or the “Company”) (NYSE/LSE: KOS) announced today that, subject to market conditions, it intends to...
PARIS--(BUSINESS WIRE)--Evercore announced today (NYSE: EVR) that Andrea Bozzi and Charles Andrez have joined the firm as senior managing directors...
SFL Corporation Ltd. (NYSE: SFL) (the "Company" or "SFL") has engaged Arctic Securities, DNB Markets and SEB to arrange a...
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced it will present...
ROAD TOWN, British Virgin Islands, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF)...
Except where otherwise noted, all currency amounts are stated in United States dollars. Unique opportunity to acquire world-scale producing methanol...
Saguenay, Quebec--(Newsfile Corp. - September 9, 2024) - First Phosphate Corp (CSE: PHOS) (OTC: FRSPF) (FSE: KD0) ("First Phosphate" or...
Implements Plan to Accelerate Business Optimization and Achieve Profitability in 2025 Initiates Voluntary Chapter 11 Process to Facilitate Restructuring Initiatives...
ROCKVILLE, MD, Sept. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing...
Abstract Released Today Highlights Favorable Safety Profile and Early Evidence of Monotherapy Anti-Tumor Activity Investor Webcast to be Held Friday,...
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced...
LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological...
SAN DIEGO, Sept. 07, 2024 (GLOBE NEWSWIRE) -- Embrace Change Acquisition Corp. (Nasdaq: EMCG, EMCGW, EMCGU, EMCGR) ("Embrace Change" or...
ANOKA, Minn.--(BUSINESS WIRE)--Vista Outdoor Inc.’s (“Vista Outdoor”, the “Company”) (NYSE: VSTO) Board of Directors today commented on MNC Capital’s (“MNC”)...
TORONTO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Cboe CA: DEFI) (GR: R9B)...
Toronto, Ontario--(Newsfile Corp. - September 6, 2024) - Roscan Gold Corporation (TSXV: ROS) (FSE: 2OJ) (OTCQB: RCGCF) ("Roscan" or the "Company") announces...
New York, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a...
AUSTIN, Texas--(BUSINESS WIRE)--Green Dot Corporation (the “Company”) (NYSE: GDOT), announced today the completion of a private placement of $45 million...
PORTLAND, Ore., Sept. 6, 2024 /PRNewswire/ -- Eastside Distilling, Inc. (Nasdaq: EAST) ("Eastside" or the "Company"), a consumer-focused beverage company...
BRANFORD, Conn.--(BUSINESS WIRE)--Azitra, Inc. (NYSE American: AZTR), a precision dermatology company announced that it announced today that Travis Whitfill, COO,...
LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological...
MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options...
CARLSBAD, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced the closing of...
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage...
LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological...
HOUSTON--(BUSINESS WIRE)--Dril-Quip, Inc. (NYSE: DRQ) (“Dril-Quip” or the “Company”), a leading developer, manufacturer and provider of highly engineered equipment and...
NEW YORK--(BUSINESS WIRE)--TPG RE Finance Trust, Inc. (NYSE: TRTX) (“TRTX” or the “Company”) today announced the Company’s Board of Directors...
WALTHAM Mass., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant...